Search research articles
Contact Us
Filters
Showing results (21-30 of 58) with videos related to
Page
of 6
Sort By:
The American Surgeon
|
February 17, 2017
Resection of Gastrointestinal Metastases in Stage IV Melanoma: Correlation with Outcomes
Sangeetha Prabhakaran, William J Fulp, Ricardo J Gonzalez, et al.
Developmental Cell
|
May 8, 2019
YAP/TAZ Inhibition Induces Metabolic and Signaling Rewiring Resulting in Targetable Vulnerabilities in NF2-Deficient Tumor Cells
Shannon M White, Maria Laura Avantaggiati, Ivan Nemazanyy, et al.
Journal for Immunotherapy of Cancer
|
December 19, 2019
Safety and efficacy of immune checkpoint inhibitors (ICIs) in cancer patients with HIV, hepatitis B, or hepatitis C viral infection
Neil J Shah, Ghassan Al-Shbool, Matthew Blackburn, et al.
Journal of Neuro-Oncology
|
December 19, 2014
LINAC-based stereotactic radiosurgery to the brain with concurrent vemurafenib for melanoma metastases
Kamran A Ahmed, Jessica M Freilich, Sarah Sloot, et al.
Journal for Immunotherapy of Cancer
|
October 12, 2018
Immune-related adverse events with immune checkpoint inhibitors affecting the skeleton: a seminal case series
Kendall F Moseley, Jarushka Naidoo, Clifton O Bingham, et al.
Journal for Immunotherapy of Cancer
|
October 2, 2021
PET/CT scan and biopsy-driven approach for safe anti-PD-1 therapy discontinuation in patients with advanced melanoma
Geoffrey T Gibney, Jacob Zaemes, Shelly Shand, et al.
Cancer Research Communications
|
December 20, 2023
Combination of Itacitinib or Parsaclisib with Pembrolizumab in Patients with Advanced Solid Tumors: A Phase I Study
Pamela Munster, Nicholas Iannotti, Daniel C Cho, et al.
Journal for Immunotherapy of Cancer
|
March 22, 2019
Phase 1/2 study of epacadostat in combination with ipilimumab in patients with unresectable or metastatic melanoma
Geoffrey T Gibney, Omid Hamid, Jose Lutzky, et al.
Molecular & Cellular Proteomics : MCP
|
April 25, 2014
Evaluating melanoma drug response and therapeutic escape with quantitative proteomics
Vito W Rebecca, Elizabeth Wood, Inna V Fedorenko, et al.
Cancer
|
October 13, 2017
Improved survival of patients with melanoma brain metastases in the era of targeted BRAF and immune checkpoint therapies
Sarah Sloot, Yian A Chen, Xiuhua Zhao, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 58) with videos related to
Sort By:
Page
of 6
The American Surgeon
|
February 17, 2017
Resection of Gastrointestinal Metastases in Stage IV Melanoma: Correlation with Outcomes
Sangeetha Prabhakaran, William J Fulp, Ricardo J Gonzalez, et al.
Developmental Cell
|
May 8, 2019
YAP/TAZ Inhibition Induces Metabolic and Signaling Rewiring Resulting in Targetable Vulnerabilities in NF2-Deficient Tumor Cells
Shannon M White, Maria Laura Avantaggiati, Ivan Nemazanyy, et al.
Journal for Immunotherapy of Cancer
|
December 19, 2019
Safety and efficacy of immune checkpoint inhibitors (ICIs) in cancer patients with HIV, hepatitis B, or hepatitis C viral infection
Neil J Shah, Ghassan Al-Shbool, Matthew Blackburn, et al.
Journal of Neuro-Oncology
|
December 19, 2014
LINAC-based stereotactic radiosurgery to the brain with concurrent vemurafenib for melanoma metastases
Kamran A Ahmed, Jessica M Freilich, Sarah Sloot, et al.
Journal for Immunotherapy of Cancer
|
October 12, 2018
Immune-related adverse events with immune checkpoint inhibitors affecting the skeleton: a seminal case series
Kendall F Moseley, Jarushka Naidoo, Clifton O Bingham, et al.
Journal for Immunotherapy of Cancer
|
October 2, 2021
PET/CT scan and biopsy-driven approach for safe anti-PD-1 therapy discontinuation in patients with advanced melanoma
Geoffrey T Gibney, Jacob Zaemes, Shelly Shand, et al.
Cancer Research Communications
|
December 20, 2023
Combination of Itacitinib or Parsaclisib with Pembrolizumab in Patients with Advanced Solid Tumors: A Phase I Study
Pamela Munster, Nicholas Iannotti, Daniel C Cho, et al.
Journal for Immunotherapy of Cancer
|
March 22, 2019
Phase 1/2 study of epacadostat in combination with ipilimumab in patients with unresectable or metastatic melanoma
Geoffrey T Gibney, Omid Hamid, Jose Lutzky, et al.
Molecular & Cellular Proteomics : MCP
|
April 25, 2014
Evaluating melanoma drug response and therapeutic escape with quantitative proteomics
Vito W Rebecca, Elizabeth Wood, Inna V Fedorenko, et al.
Cancer
|
October 13, 2017
Improved survival of patients with melanoma brain metastases in the era of targeted BRAF and immune checkpoint therapies
Sarah Sloot, Yian A Chen, Xiuhua Zhao, et al.
Page
of 6